Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: The role of coffee in the development of hepatocellular carcinoma (HCC) is debated. The aim of this study was to investigate the role of coffee in HCC, taking the main risk factors into account. METHODS: A hospital-based case-control study was conducted in an area of northern Italy. We recruited 250 HCC cases and 500 controls hospitalized for any reasons other than neoplasms, and liver and alcohol-related diseases. Subjects were interviewed on their lifetime history of coffee consumption using a standardized questionnaire. RESULTS: Coffee consumption in the decade before the interview was associated with a decreasing risk of HCC with a clear dose-effect relation. With respect to non-drinking subjects, the odds ratios (ORs) were: 0.8, (95% CI 0.4-1.3) for 1-2 cups/day, 0.4 (95% CI 0.2-0.8) for 3-4 cups/day and 0.3 (95% CI 0.1-0.7) for 5 or more cups/day. The ORs for HCC decreased for drinking >2, compared to 0-2 cups/day of coffee, for an alcohol intake >80 g/day (OR from 5.7 to 3.3), for presence of hepatitis B virus infection (OR from 16.4 to 7.3) or hepatitis C virus infection (OR from 38.2 to 9.0). CONCLUSIONS: Coffee drinking was inversely associated with HCC regardless of its aetiology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cafestol and Kahweol, Two Coffee Specific Diterpenes with Anticarcinogenic Activity
Cavin, C., Holzhaeuser, D., Scharf, G., Constable, A., Huber, W. W., & Schilter, B. (2002) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(02)00029-7 · Cited by 422
Mori, M., Hara, M., Wada, I., Hara, T., Yamamoto, K., Honda, M., & Naramoto, J. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010180 · Cited by 144 · cited 1×
“We found no association between cigarette smoking and HCC, in agreement with other research [26–30].”
Result
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
El–Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,415
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Singal, A. G., Lampertico, P., & Nahon, P. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.025 · Cited by 1,102
Coffee and Health: A Review of Recent Human Research
Higdon, J. V., & Frei, B. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500400009 · Cited by 1,090
Coffee and its Consumption: Benefits and Risks
Butt, M. S., & Sultan, M. T. (2011) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390903586412 · Cited by 612
Coffee: Biochemistry and Potential Impact on Health
Ludwig, I. A., Clifford, M. N., Lean, M. E. J., Ashihara, H., & Crozier, A. (2014) · Food Funct. · doi:10.1039/c4fo00042k · Cited by 537
Hepatocellular carcinoma epidemiology
Bosetti, C., Turati, F., & La Vecchia, C. (2014) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2014.08.007 · Cited by 530
Korean Liver Cancer Association, K., & National Cancer Center, N. (2019) · Gut and Liver · doi:10.5009/gnl19024 · Cited by 391
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Korean Liver Cancer Association (KLCA) and National Cancer Center (NCC) Korea (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0294 · Cited by 343
Molloy, J. W., Calcagno, C. J., Williams, C. D., Jones, F. J., Torres, D. M., & Harrison, S. A. (2012) · Hepatology · doi:10.1002/hep.24731 · Cited by 315
Increased Caffeine Consumption Is Associated With Reduced Hepatic Fibrosis
Modi, A. A., Feld, J. J., Park, Y., Kleiner, D. E., Everhart, J. E., Liang, J. T., & Hoofnagle, J. H. (2010) · Hepatology · doi:10.1002/hep.23279 · Cited by 279
Chemopreventive strategies in hepatocellular carcinoma
Singh, S., Singh, P. P., Roberts, L. R., & Sanchez, W. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.143 · Cited by 273
Niemelä, O. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.08.035 · Cited by 262
Coffee Reduces Risk for Hepatocellular Carcinoma: An Updated Meta-analysis
Bravi, F., Bosetti, C., Tavani, A., Gallus, S., & La Vecchia, C. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.039 · Cited by 253
Phytochemicals as Protectors Against Ultraviolet Radiation: Versatility of Effects and Mechanisms
Dinkova-Kostova, A. (2008) · Planta Medica · doi:10.1055/s-2008-1081296 · Cited by 136
Bhurwal, A., Ratta, P., Yoshitake, S., Pioppo, L., Reja, D., Dellatore, P., & Rustgi, V. (2020) · Journal of Gastrointestinal and Liver Diseases · doi:10.15403/jgld-805 · Cited by 61
“Study Country Type of Study Case Cohort Control Exposure evaluation Outcome evaluation Cases Kuper et al. [35] Greece Case Control Hospitalized population Non cancer hospital pts. Questionnaire Medical records 333 cases Gallus et al. (2 Cohorts) [24] Italy, Greece Case Control Hospitalized cohort Non cancer hospital p…”
BackgroundInfluential
Metadata
- Authors
- GELATTI, U., COVOLO, L., FRANCESCHINI, M., PIRALI, F., TAGGER, A., RIBERO, M., TREVISI, P., MARTELLI, C., NARDI, G., & DONATO, F.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2005-04
- Volume
- 42
- Issue
- 4
- Pages
- 528-534
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2063390008
- Cited by
- 186
- References
- 2
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.